RADX
NASD Radiopharm Theranostics Limited Sponsored ADR$1.11 ↑ +0.00 (+0.00%) Trading Up from the previous close of $1.11, $0.05 below the day’s high of $1.16
- YTD change
- -78.74%
- vs 20-day SMA
- -30.38%
- vs 200-day SMA
- -72.50%
Price ranges
Price & Performance
-3.37 (-75.22%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 97.8% away from all-time highs of $50.82
- RADX is down 79% since the beginning of the year
- RADX is down 85% over the past 12 months
- RADX is down 47% over the past 1 month
- 0% of all RADX investors are betting against RADX
RADX reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -85.3%.
- Previous minute
- +$0.00
- Last hour
- -$0.03
- Last 5 days
- -31.48%
- vs 8-day SMA
- -20.43%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Radiopharm Theranostics Ltd. operates as a pre-clinical and clinical research company. It focuses on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need. The company was founded by Paul A. Hopper in 2021 and is headquartered in Carlton, Australia.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.